Erlotinib-associated alopecia in a lung cancer patient

J Thorac Oncol. 2007 Dec;2(12):1136-8. doi: 10.1097/JTO.0b013e31815ba7f9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Alopecia / chemically induced*
  • Alopecia / physiopathology
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Erlotinib Hydrochloride
  • Female
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Protein Kinase Inhibitors / adverse effects
  • Protein Kinase Inhibitors / therapeutic use
  • Quinazolines / adverse effects*
  • Quinazolines / therapeutic use
  • Risk Assessment

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride